scholarly article | Q13442814 |
P356 | DOI | 10.1111/BPA.12293 |
P698 | PubMed publication ID | 26222673 |
P50 | author | Supriya Mallick | Q38546872 |
P2093 | author name string | Chitra Sarkar | |
Aanchal Kakkar | |||
Ashish Suri | |||
Deepak Gupta | |||
Vaishali Suri | |||
Mehar C Sharma | |||
Anupam Kumar | |||
Pramod K Julka | |||
Kavneet Kaur | |||
P2860 | cites work | Molecular subgroups of medulloblastoma: the current consensus | Q24615271 |
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci | Q28236937 | ||
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee | Q28279527 | ||
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies | Q28282708 | ||
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
Rapid diagnosis of medulloblastoma molecular subgroups | Q34764793 | ||
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples | Q35837393 | ||
Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement | Q36048155 | ||
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 | ||
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables | Q36476670 | ||
Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. | Q36631618 | ||
Genetic grouping of medulloblastomas by representative markers in pathologic diagnosis | Q36865020 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma | Q36929844 | ||
Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study | Q37246499 | ||
Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas | Q37312706 | ||
Cytogenetic prognostication within medulloblastoma subgroups | Q37627692 | ||
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading | Q38225758 | ||
Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours | Q39181104 | ||
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis | Q39828521 | ||
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations | Q40339027 | ||
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. | Q42739353 | ||
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial | Q45120061 | ||
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone | Q46367739 | ||
Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. | Q47340801 | ||
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. | Q48213578 | ||
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. | Q53286039 | ||
Adult medulloblastoma comprises three major molecular variants. | Q55463035 | ||
P433 | issue | 3 | |
P304 | page(s) | 334-343 | |
P577 | publication date | 2015-07-29 | |
P1433 | published in | Brain Pathology | Q4955776 |
P1476 | title | Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach | |
P478 | volume | 26 |
Q64065929 | A simplified approach using Taqman low-density array for medulloblastoma subgrouping |
Q51542148 | Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. |
Q48151439 | Expression of microRNAs in tumors of the central nervous system in pediatric patients in México |
Q28079423 | Indian data on central nervous tumors: A summary of published work |
Q51731284 | Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation. |
Q42591772 | Next-generation sequencing of central nervous systems tumors: the future of personalized patient management |
Q31145092 | Recent advances in subtyping tumors of the central nervous system using molecular data |
Q41989047 | Risk factors for the prognosis of pediatric medulloblastoma: a retrospective analysis of 40 cases |
Q38670567 | The Diagnostic Use of Immunohistochemical Surrogates for Signature Molecular Genetic Alterations in Gliomas |
Q36288376 | Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups |
Q37391485 | Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline |